跳至主要内容
临床试验/NCT07536152
NCT07536152招募中4 期

Prophylactic Antihistamine for Prevention of Hypotensive Transfusion Reaction After Blood Primed Cardiopulmonary Bypass in Pediatric Cardiac Surgery: a Randomized-controlled Study

Kasr El Aini Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
hypotention episode incidance

研究概览

简要总结

This study will be a randomized, double-blinded, placebo-controlled study conducted at a university hospital. Forty children undergoing elective repair of a congenital heart defect will be included. The patients will be randomly allocated (20 patients per group) to receive a single intravenous dose of combined chlorpheniramine or normal saline immediately after separation from CPB, before protamine administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Acyanotic congenital heart disease.
  • Age :1 -7 years.
  • Genre: both.

排除标准

  • Redo patient.
  • History of allergy to antihistamines.
  • Bleeding disorders with INR > 1.5 and/or platelets < 50,
  • Emergency procedure.

研究组 & 干预措施

Antihistamine

Active Comparator

chlorpheniramine 0.25 mg/Kg in 2 ml

干预措施: Antihestamine (Drug)

control

Placebo Comparator

equal volume of normal saline

干预措施: Placebo (Drug)

结局指标

主要结局

hypotention episode incidance

时间窗: 15 min,post cardiopulmonary bypass weaning

Incidence of hypotension (20% MBP drop \< baseline)15 minutes post-CBP weaning

次要结局

未报告次要终点

研究者

发起方
Kasr El Aini Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Mohamed Elhaddad

assisstant professor

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验